Literature DB >> 33572767

Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment.

Peter Hutka1, Michaela Krivosova2, Zuzana Muchova1, Ingrid Tonhajzerova3, Andrea Hamrakova1,3, Zuzana Mlyncekova1, Juraj Mokry2, Igor Ondrejka1.   

Abstract

Sleep problems are frequently associated with the principal diagnostic criteria for many mental disorders. Alterations in the sleep of depressive patients are of high clinical significance because continuous sleep problems raise the chance of relapse, recurrence, or suicide, as well as the need for augmenting medications. Most antidepressants have been proven to influence the sleep architecture. While some classes of antidepressants improve sleep, others may cause sleep impairment. The successful treatment of depressive disorder also requires an understanding of the effects of antidepressants on sleep. This article briefly reviews the physiology of sleep and the typical alterations in the sleep architecture in depressive patients and updates the different effects of the majority of antidepressants including novel drugs in clinical practice on sleep. The summary of the updated scientific findings of the relationship between depression and sleep disturbances could be clinically beneficial in choosing the best medication for depressive patients with concurrent sleep disorders.

Entities:  

Keywords:  antidepressants; depression; depressive disorder; polysomnography; sleep

Mesh:

Substances:

Year:  2021        PMID: 33572767      PMCID: PMC7866255          DOI: 10.3390/ijms22031333

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  118 in total

1.  Nefazodone--a novel antidepressant--may increase REM sleep.

Authors:  A L Sharpley; A E Walsh; P J Cowen
Journal:  Biol Psychiatry       Date:  1992-05-15       Impact factor: 13.382

Review 2.  Neurophysiology of sleep and wakefulness.

Authors:  Cameron D Harris
Journal:  Respir Care Clin N Am       Date:  2005-12

3.  Effects of fluoxetine on the polysomnogram in outpatients with major depression.

Authors:  M H Trivedi; A J Rush; R Armitage; C M Gullion; B D Grannemann; P J Orsulak; H P Roffwarg
Journal:  Neuropsychopharmacology       Date:  1999-05       Impact factor: 7.853

Review 4.  Sleep as a biomarker for depression.

Authors:  Adam Wichniak; Aleksandra Wierzbicka; Wojciech Jernajczyk
Journal:  Int Rev Psychiatry       Date:  2013-10

5.  Peeking into the minds of troubled adolescents: the utility of polysomnography sleep studies in an inpatient psychiatric unit.

Authors:  Azmeh Shahid; Arash Khairandish; Bojana Gladanac; Colin Shapiro
Journal:  J Affect Disord       Date:  2012-03-11       Impact factor: 4.839

6.  A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.

Authors:  R Luthringer; M Toussaint; N Schaltenbrand; P Bailey; P H Danjou; D Hackett; J Y Guichoux; J P Macher
Journal:  Psychopharmacol Bull       Date:  1996

7.  Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population.

Authors:  M M Ohayon; C M Shapiro
Journal:  Compr Psychiatry       Date:  2000 Nov-Dec       Impact factor: 3.735

8.  Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.

Authors:  Hans-Peter Landolt; John R Kelsoe; Marc H Rapaport; J Christian Gillin
Journal:  J Sleep Res       Date:  2003-03       Impact factor: 3.981

9.  REM sleep enhancement by bupropion in depressed men.

Authors:  E A Nofzinger; C F Reynolds; M E Thase; E Frank; J R Jennings; A L Fasiczka; L R Sullivan; D J Kupfer
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

Review 10.  Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.

Authors:  Ronald S Duman; Ryota Shinohara; Manoela V Fogaça; Brendan Hare
Journal:  Mol Psychiatry       Date:  2019-03-20       Impact factor: 15.992

View more
  6 in total

1.  New-Onset Sleepwalking in a Patient Treated With Buspirone.

Authors:  Tabitha E H Moses; Arash Javanbakht
Journal:  J Clin Psychopharmacol       Date:  2022 Jan-Feb 01       Impact factor: 3.153

Review 2.  Actigraphy monitoring in anxiety disorders: A mini-review of the literature.

Authors:  Martin Pastre; Jorge Lopez-Castroman
Journal:  Front Psychiatry       Date:  2022-08-03       Impact factor: 5.435

3.  Nightmare Distress as a Risk Factor for Suicide Among Adolescents with Major Depressive Disorder.

Authors:  Tian-He Song; Ting-Ting Wang; Yun-Yue Zhuang; Hua Zhang; Jun-Hui Feng; Tang-Ren Luo; Shuang-Jiang Zhou; Jing-Xu Chen
Journal:  Nat Sci Sleep       Date:  2022-09-22

4.  Cognitive Behavioral Therapy for Chronic Insomnia in Outpatients with Major Depression-A Randomised Controlled Trial.

Authors:  Henny Dyrberg; Bjørn Bjorvatn; Erik Roj Larsen
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

Review 5.  Current Perspectives on the Impact of Chronic Migraine on Sleep Quality: A Literature Review.

Authors:  Hikmet Saçmacı; Nermin Tanik; Levent Ertuğrul İnan
Journal:  Nat Sci Sleep       Date:  2022-10-06

Review 6.  Migraine and Sleep-An Unexplained Association?

Authors:  Marta Waliszewska-Prosół; Marta Nowakowska-Kotas; Justyna Chojdak-Łukasiewicz; Sławomir Budrewicz
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.